Your browser doesn't support javascript.
loading
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.
Chen, Hao; Hu, Zhihang; Xu, Qingguo; He, Chiyu; Yang, Xinyu; Shen, Wei; Lin, Zuyuan; Li, Huigang; Zhuang, Li; Cai, Jinzhen; Lerut, Jan; Zheng, Shusen; Lu, Di; Xu, Xiao.
Afiliação
  • Chen H; Zhejiang University, School of Medicine.
  • Hu Z; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Xu Q; Zhejiang University, School of Medicine.
  • He C; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Yang X; Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
  • Shen W; Zhejiang University, School of Medicine.
  • Lin Z; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Li H; Zhejiang University, School of Medicine.
  • Zhuang L; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Cai J; Zhejiang University, School of Medicine.
  • Lerut J; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Zheng S; Zhejiang University, School of Medicine.
  • Lu D; Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health.
  • Xu X; Zhejiang University, School of Medicine.
Int J Surg ; 110(6): 3543-3553, 2024 Jun 01.
Article em En | MEDLINE | ID: mdl-38489552
ABSTRACT

BACKGROUND:

Split liver transplantation (SLT) increases graft availability, but it's safe and effective utilization is insufficiently documented. This study aimed to investigate the association between perioperative body composition abnormalities and outcomes in adult SLT. MATERIALS AND

METHODS:

Two hundred forty recipients who underwent SLT in three centers were enrolled in this retrospective cohort study. Body composition abnormalities including sarcopenia, myosteatosis, visceral obesity, and sarcopenic obesity were evaluated at baseline and 1 month after surgery using computed tomography. Their impact on outcomes including early allograft dysfunction, early complications, ICU stay, graft regeneration rate, and survival was analyzed.

RESULTS:

Recipients with sarcopenia or myosteatosis had a higher risk of early allograft dysfunction, higher early complication rate, and longer length of ICU stay (all P <0.05), while there was no difference in graft regeneration rate. Recipient and graft survival were significantly worse for recipients with body composition abnormalities (all P <0.05). In multivariable Cox-regression analysis, sarcopenia [hazard ratio (HR)=1.765, P =0.015], myosteatosis (HR=2.066, P =0.002), and visceral obesity (HR=1.863, P =0.008) were independently associated with shorter overall survival. Piling up of the three factors increased the mortality risk stepwise ( P <0.001). Recipients experienced skeletal muscle loss and muscle fat infiltration 1 month after surgery. Postoperative worsening sarcopenia (HR=2.359, P =0.009) and myosteatosis (HR=1.878, P =0.026) were also identified as independent risk factors for mortality.

CONCLUSION:

Sarcopenia, myosteatosis, and their progression negatively affect outcomes including early allograft dysfunction, early complications, ICU stay and survival after SLT. Systemic evaluation and dynamic monitoring of body composition are valuable.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Composição Corporal / Transplante de Fígado / Sarcopenia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Composição Corporal / Transplante de Fígado / Sarcopenia Idioma: En Ano de publicação: 2024 Tipo de documento: Article